Literature DB >> 4345055

Characterization of subfractions of triglyceride-rich lipoproteins separated by gel chromatography from blood plasma of normolipemic and hyperlipemic humans.

T Sata, R J Havel, A L Jones.   

Abstract

As judged from measurements of the diameters of particles fixed with osmium tetroxide and shadowed with platinum, gel chromatography on 2% agarose has been shown to be an effective quantitative method for separating triglyceride-rich lipoproteins according to particle size. Particles in the size range of chylomicrons, uncontaminated by lipoproteins smaller than about 700 A or by other serum proteins, emerged in the void volume of the column, and very low density lipoproteins with diameters between 400 and 700 A were separated into fractions with average standard deviation of 71 A from the mean. Systematic comparison of the relationship between diameter and chemical composition of fractions obtained from subjects with various hyperlipoproteinemic disorders demonstrated a precise correlation consistent with a spherical model for these lipoproteins in which phospholipids, free cholesterol, and protein occupy a surface monolayer with an invariant thickness of 21.5 A surrounding a liquid core of triglycerides and cholesteryl esters. The chemical composition of very low density lipoproteins of given particle size in most recognized types of hyperlipemia was similar to that of normolipemic subjects, but particles in the size range of chylomicrons sometimes had higher contents of cholesteryl esters and free cholesterol. Results obtained in subjects with dysbetalipoproteinemia were consistent with the presence of three populations of particles. Two of these, with mean diameters of about 850 and 350 A, had unusually high cholesteryl ester content and reduced triglyceride content and may represent "remnants" of the metabolism of structurally normal chylomicrons and very low density lipoproteins, respectively. The third, a heterogeneous group with intermediate range of particle size and pre-beta mobility, may represent a population of very low density lipoproteins with relatively normal composition.

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 4345055

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  41 in total

Review 1.  The physiology of lipoproteins.

Authors:  Thomas N Tulenko; Anne E Sumner
Journal:  J Nucl Cardiol       Date:  2002 Nov-Dec       Impact factor: 5.952

2.  The role of high density lipoprotein apolipoprotein CII in triglyceride metabolism.

Authors:  M L Kashyap; L S Srivastava; B A Hynd; G Perisutti; D W Brady; P Gartside; C J Glueck
Journal:  Lipids       Date:  1978-12       Impact factor: 1.880

Review 3.  Hepatic ABCA1 and VLDL triglyceride production.

Authors:  Mingxia Liu; Soonkyu Chung; Gregory S Shelness; John S Parks
Journal:  Biochim Biophys Acta       Date:  2011-10-06

4.  The human asialoglycoprotein receptor is a possible binding site for low-density lipoproteins and chylomicron remnants.

Authors:  E Windler; J Greeve; B Levkau; V Kolb-Bachofen; W Daerr; H Greten
Journal:  Biochem J       Date:  1991-05-15       Impact factor: 3.857

5.  Characterization of remnants produced during the metabolism of triglyceride-rich lipoproteins of blood plasma and intestinal lymph in the rat.

Authors:  O D Mjos; O Faergeman; R L Hamilton; R J Havel
Journal:  J Clin Invest       Date:  1975-09       Impact factor: 14.808

6.  Metabolism of cholesteryl esters of rat very low density lipoproteins.

Authors:  O Faergeman; R J Havel
Journal:  J Clin Invest       Date:  1975-06       Impact factor: 14.808

7.  The metabolic fate of high density lipoprotein (HDL) in the diabetic rat.

Authors:  H Bar-On; S Eisenberg
Journal:  Diabetologia       Date:  1978-01-14       Impact factor: 10.122

8.  High receptor binding affinity of lipoproteins in atypical dysbetalipoproteinemia (type III hyperlipoproteinemia).

Authors:  D A Chappell
Journal:  J Clin Invest       Date:  1989-12       Impact factor: 14.808

9.  Regulation of serum apolipoprotein E metabolism: role of chylomicron metabolism.

Authors:  J G DeLamatre; B R Krause; P S Roheim
Journal:  Proc Natl Acad Sci U S A       Date:  1982-02       Impact factor: 11.205

10.  Abnormalities in very low, low and high density lipoproteins in hypertriglyceridemia. Reversal toward normal with bezafibrate treatment.

Authors:  S Eisenberg; D Gavish; Y Oschry; M Fainaru; R J Deckelbaum
Journal:  J Clin Invest       Date:  1984-08       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.